Metastatic castration-resistant prostate cancer: new therapies, novel combination strategies and implications for immunotherapy

Oncogene ◽

10.1038/onc.2013.497 ◽

2013 ◽

Vol 33 (43) ◽

pp. 5053-5064 ◽

Author(s):

C G Drake ◽

P Sharma ◽

W Gerritsen

Keyword(s):

Prostate Cancer ◽

Castration Resistant Prostate Cancer ◽

New Therapies ◽

Combination Strategies ◽

Castration Resistant

Download Full-text

New therapies for relapsed castration-resistant prostate cancer based on peptide analogs of hypothalamic hormones

Asian Journal of Andrology ◽

10.4103/1008-682x.152819 ◽

2015 ◽

Vol 17 (6) ◽

pp. 925 ◽

Author(s):

AndrewV Schally ◽

NormanL Block ◽

FerencG Rick

Keyword(s):

Prostate Cancer ◽

Castration Resistant Prostate Cancer ◽

New Therapies ◽

Castration Resistant ◽

Peptide Analogs ◽

Hypothalamic Hormones

Download Full-text

A Systematic Review of the Emerging Role of Immune Checkpoint Inhibitors in Metastatic Castration-resistant Prostate Cancer: Will Combination Strategies Improve Efficacy?

European Urology Oncology ◽

10.1016/j.euo.2020.10.010 ◽

2020 ◽

Author(s):

Isabel Heidegger ◽

Andrea Necchi ◽

Andreas Pircher ◽

Igor Tsaur ◽

Giancarlo Marra ◽

...

Keyword(s):

Prostate Cancer ◽

Systematic Review ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitors ◽

Checkpoint Inhibitors ◽

Castration Resistant Prostate Cancer ◽

Combination Strategies ◽

Castration Resistant

Download Full-text

Use of New Therapies and Hospital Admission Near the End of Life in Castration Resistant Prostate Cancer (CRPC) in the Castration Resistant Prostate Cancer Registry (CAPRI) in the Netherlands

Value in Health ◽

10.1016/j.jval.2017.08.009 ◽

2017 ◽

Vol 20 (9) ◽

pp. A400

Author(s):

M Kuppen ◽

H Westgeest ◽

A Van den Eertwegh ◽

W Gerritsen ◽

C Uyl - de Groot

Keyword(s):

Prostate Cancer ◽

The Netherlands ◽

Hospital Admission ◽

End Of Life ◽

Cancer Registry ◽

Castration Resistant Prostate Cancer ◽

New Therapies ◽

Castration Resistant

Download Full-text

Clinical Efficacy And Safety Of Licensed Drugs And Potential New Therapies For Non-Metastatic Castration-Resistant Prostate Cancer: A Systematic Literature Review

Value in Health ◽

10.1016/j.jval.2017.08.340 ◽

2017 ◽

Vol 20 (9) ◽

pp. A458

Author(s):

S Naidoo ◽

I Smith ◽

M Casamayor

Keyword(s):

Prostate Cancer ◽

Literature Review ◽

Clinical Efficacy ◽

Systematic Literature Review ◽

Efficacy And Safety ◽

Castration Resistant Prostate Cancer ◽

New Therapies ◽

Castration Resistant

Download Full-text

New Therapies for Castration-Resistant Prostate Cancer

New England Journal of Medicine ◽

10.1056/nejme1006300 ◽

2010 ◽

Vol 363 (5) ◽

pp. 479-481 ◽

Author(s):

Dan L. Longo

Keyword(s):

Prostate Cancer ◽

Castration Resistant Prostate Cancer ◽

New Therapies ◽

Castration Resistant

Download Full-text

New Therapies for Castration-Resistant Prostate Cancer: Efficacy and Safety

European Urology ◽

10.1016/j.eururo.2011.04.038 ◽

2011 ◽

Vol 60 (2) ◽

pp. 279-290 ◽

Author(s):

Himisha Beltran ◽

Tomasz M. Beer ◽

Michael A. Carducci ◽

Johann de Bono ◽

Martin Gleave ◽

...

Keyword(s):

Prostate Cancer ◽

Efficacy And Safety ◽

Castration Resistant Prostate Cancer ◽

New Therapies ◽

Castration Resistant

Download Full-text

Impact of new therapies in the treatment of metastatic Castration Resistant Prostate Cancer (CPRCm): Retrospective analysis in a single institution in 2005-2015

European Urology Supplements ◽

10.1016/s1569-9056(16)30453-5 ◽

2016 ◽

Vol 15 (13) ◽

pp. e1668

Author(s):

Pous A. Font ◽

J. Piulats ◽

O. Etxaniz ◽

N. Sala ◽

L. Heras ◽

...

Keyword(s):

Prostate Cancer ◽

Retrospective Analysis ◽

Castration Resistant Prostate Cancer ◽

Single Institution ◽

New Therapies ◽

Castration Resistant

Download Full-text

Re: Himisha Beltran, Tomasz M. Beer, Michael A. Carducci, et al. New Therapies for Castration-Resistant Prostate Cancer: Efficacy and Safety. Eur Urol 2011;60:279–90

European Urology ◽

10.1016/j.eururo.2011.06.054 ◽

2011 ◽

Vol 60 (4) ◽

pp. e33

Author(s):

Alain Braillon

Keyword(s):

Prostate Cancer ◽

Efficacy And Safety ◽

Castration Resistant Prostate Cancer ◽

New Therapies ◽

Castration Resistant

Download Full-text

Neuroendocrine secretory profiles are not associated with treatment response to Lu-177-PSMA-617 radioligand therapy in patients with advanced metastatic castration-resistant prostate cancer

10.1055/s-0040-1708342 ◽

2020 ◽

Author(s):

T Derlin ◽

R Werner ◽

C Henkenberens ◽

TL Ross ◽

FM Bengel

Keyword(s):

Prostate Cancer ◽

Treatment Response ◽

Castration Resistant Prostate Cancer ◽

Radioligand Therapy ◽

Castration Resistant

Download Full-text

Prostate specific membrane antigen targeted radioligand therapy of metastatic castration-resistant prostate cancer using Lu-177 PSMA-617: safety, efficacy and dosimetry in comparison with Lu-177 PSMA I&T

Endocrine Abstracts ◽

10.1530/endoabs.47.oc32 ◽

2016 ◽

Author(s):

Harshad R. Kulkarni ◽

Aviral Singh ◽

Christiane Schuchardt ◽

Karin Niepsch ◽

Richard P. Baum

Keyword(s):

Prostate Cancer ◽

Prostate Specific Membrane Antigen ◽

Castration Resistant Prostate Cancer ◽

Radioligand Therapy ◽

Castration Resistant ◽

Specific Membrane

Download Full-text